scispace - formally typeset
Journal ArticleDOI

Exploring miRNA based approaches in cancer diagnostics and therapeutics.

Reads0
Chats0
TLDR
The molecularly different tumors can be differentiated by specific miRNA profiling as their phenotypic signatures, which can hence be exploited to surmount the diagnostic and therapeutic challenges.
Abstract
MicroRNAs (miRNAs), a highly conserved class of tissue specific, small non-protein coding RNAs maintain cell homeostasis by negative gene regulation. Proper controlling of miRNA expression is required for a balanced physiological environment, as these small molecules influence almost every genetic pathway from cell cycle checkpoint, cell proliferation to apoptosis, with a wide range of target genes. Deregulation in miRNAs expression correlates with various cancers by acting as tumor suppressors and oncogenes. Although promising therapies exist to control tumor development and progression, there is a lack of efficient diagnostic and therapeutic approaches for delineating various types of cancer. The molecularly different tumors can be differentiated by specific miRNA profiling as their phenotypic signatures, which can hence be exploited to surmount the diagnostic and therapeutic challenges. Present review discusses the involvement of miRNAs in oncogenesis with the analysis of patented research available on miRNAs.

read more

Citations
More filters
Journal ArticleDOI

LncRNA XIST Promotes Pancreatic Cancer Proliferation Through miR-133a/EGFR.

TL;DR: Light is shed on the role and mechanism of XIST/miR‐133a/EGFR in regulating PC cells proliferation and XIST may serve as a potential therapeutic target in PC in the future.
Journal ArticleDOI

The long non-coding RNA TP73-AS1 modulates HCC cell proliferation through miR-200a-dependent HMGB1/RAGE regulation.

TL;DR: The data indicated that TP73-AS1 might be an oncogenic lncRNA that promoted proliferation of HCC and could be regarded as a therapeutic target in human HCC.
Journal ArticleDOI

Editorial focus: understanding off-target effects as the key to successful RNAi therapy

TL;DR: The objective of this article is to briefly summarize the basics of RNAi therapy, as well as to discuss how to translate basic research into better understanding of related drug candidate safety profiles early in the process.
Journal ArticleDOI

Correlating serum micrornas and clinical parameters in amyotrophic lateral sclerosis.

TL;DR: The findings identified serum miRNAs that can serve as biomarkers for ALS diagnosis and progression that correlated positively and negatively with changes in clinical parameters in longitudinal analysis.
Journal ArticleDOI

The miR-186-3p/EREG axis orchestrates tamoxifen resistance and aerobic glycolysis in breast cancer cells.

TL;DR: A novel molecular mechanism of resistance to hormone therapies in which the miR-186-3p/EREG axis orchestrates tamoxifen resistance and aerobic glycolysis in ER-positive breast cancer is revealed, suggesting targeting miR/EREG as a promising strategy for therapeutic intervention in endocrine-resistant breast tumors.
References
More filters
Journal ArticleDOI

Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis.

TL;DR: The usefulness of circulating miRNA for cancer diagnosis, prognosis, and therapeutics is summarized and a mechanism for the secretion and incorporation of miRNA into the cells is proposed.
Journal ArticleDOI

The miR-34 family in cancer and apoptosis.

TL;DR: The evidence for a role of miR-34a and miR/c in the apoptotic response of normal and tumor cells is surveyed and has been linked to resistance against apoptosis induced by p53 activating agents used in chemotherapy.
Journal ArticleDOI

Modulation of microRNA processing by p53

TL;DR: This study reveals a previously unrecognized function of p53 in miRNA processing, which may underlie key aspects of cancer biology, and suggests that transcription-independent modulation of miRNA biogenesis is intrinsically embedded in a tumour suppressive program governed by p53.
PatentDOI

Pre-b cell proliferation and lymphoblastic leukemia/high-grade lymphoma in mir155 transgenic mice

TL;DR: In this article, a method of testing the therapeutic efficacy of an agent in treating or preventing a lymphoproliferative condition includes assessing the effect(s) of the agent on a transgenic non-human animal.
Journal ArticleDOI

OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma

TL;DR: It is shown that overexpression of miR-21 leads to a pre-B malignant lymphoid-like phenotype, demonstrating that mir-21 is a genuine oncogene and demonstrating efforts to treat human cancers through pharmacological inactivation of miRNAs such as miR -21.
Related Papers (5)